Ark. Code Ann. § 5-64-101 (2026)
Definitions
As used in this chapter:
-
“Administer” means the direct application of a controlled substance, whether by injection, inhalation, ingestion, or any other means to the body of a patient or research subject by:
- A practitioner; or
- The patient or research subject at the direction and in the presence of the practitioner;
-
- “Agent” means an authorized person who acts on behalf of or at the direction of a manufacturer, distributor, or dispenser.
- “Agent” does not include a common or contract carrier, public warehouseman, or employee of the common or contract carrier or warehouseman;
-
- “Anabolic steroid” means any drug or hormonal substance, chemically and pharmacologically related to testosterone, other than estrogens, progestin, and corticosteroid that promotes muscle growth.
-
- “Anabolic steroid” does not include an anabolic steroid that is expressly intended for administration through an implant to cattle or another nonhuman species and that has been approved by the Secretary of the Department of Health for such administration.
- If any person prescribes, dispenses, or distributes a steroid described in subdivision (3)(B)(i) of this section for human use, the person is considered to have prescribed, dispensed, or distributed an anabolic steroid within the meaning of this subdivision (3);
- “Controlled substance” means a drug, substance, or immediate precursor in Schedules I through VI;
-
- “Counterfeit substance” means a noncontrolled substance, that by overall dosage unit appearance including color, shape, size, markings, packaging, labeling, and overall appearance or upon the basis of representations made to the recipient, purports to be a controlled substance or to have the physical or psychological effect associated with a controlled substance.
-
In determining whether a substance is a “counterfeit substance”, the following factors shall be utilized and a finding of any two (2) of these factors constitutes prima facie evidence that the substance is a “counterfeit substance”:
- A statement made by an owner or by anyone else in control of the substance concerning the nature of the substance, its use, or effect;
- The physical appearance of the finished product containing the noncontrolled substance is substantially the same as that of a specific controlled substance;
- The noncontrolled substance is unpackaged or is packaged in a manner normally used for the illegal delivery of a controlled substance;
- The noncontrolled substance is not labeled in accordance with 21 U.S.C. § 352 or 21 U.S.C. § 353;
- The person delivering, attempting to deliver, or causing delivery of the noncontrolled substance states or represents to the recipient that the noncontrolled substance may be resold at a price that substantially exceeds the value of the substance;
- An evasive tactic or action utilized by the owner or person in control of the substance to avoid detection by a law enforcement authority; or
- A prior conviction, if any, of an owner, or anyone in control of the object under a state or federal law related to a controlled substance or fraud;
- “Deliver” or “delivery” means the actual, constructive, or attempted transfer from one (1) person to another of a controlled substance or counterfeit substance in exchange for money or anything of value, whether or not there is an agency relationship;
- “Dispense” means to deliver a controlled substance to an ultimate user or research subject by or pursuant to the lawful order of a practitioner, including the prescribing, administering, packaging, labeling, or compounding necessary to prepare the controlled substance for that delivery;
- “Dispenser” means a practitioner who dispenses;
- “Distribute” means to deliver other than by administering or dispensing a controlled substance;
- “Distributor” means a person who distributes;
-
-
“Drug” means a substance:
- Recognized as a drug in the official United States Pharmacopoeia, official Homeopathic Pharmacopoeia of the United States, official National Formulary, or any supplement to any of them;
- Intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in humans or animals;
- Other than food intended to affect the structure or any function of the body of humans or animals; and
- Intended for use as a component of any article specified in subdivision (11)(A)(i), subdivision (11)(A)(ii), or subdivision (11)(A)(iii) of this section.
- “Drug” does not include a device or its components, parts, or accessories;
-
“Drug” means a substance:
-
- “Drug paraphernalia” means any equipment, product, and material of any kind that are used, intended for use, or designed for use in planting, propagating, cultivating, growing, harvesting, manufacturing, compounding, converting, producing, processing, preparing, testing, analyzing, packaging, repackaging, storing, containing, concealing, injecting, ingesting, inhaling, or otherwise introducing into the human body a controlled substance in violation of this chapter.
-
“Drug paraphernalia” includes, but is not limited to:
- A kit used, intended for use, or designed for use in planting, propagating, cultivating, growing, or harvesting any species of plant that is a controlled substance or from which a controlled substance can be derived;
- A kit used, intended for use, or designed for use in manufacturing, compounding, converting, producing, processing, or preparing a controlled substance;
- An isomerization device used, intended for use, or designed for use in increasing the potency of any species of plant that is a controlled substance;
- Testing equipment used, intended for use, or designed for use in identifying or in analyzing the strength, effectiveness, or purity of a controlled substance;
- A scale or balance used, intended for use, or designed for use in weighing or measuring a controlled substance;
- A diluent or adulterant, such as quinine hydrochloride, mannitol, mannite, dextrose, and lactose used, intended for use, or designed for use in cutting a controlled substance;
- A separation gin or sifter used, intended for use, or designed for use in removing a twig or seed from, or in otherwise cleaning or refining, marijuana;
- A blender, bowl, container, spoon, or mixing device used, intended for use, or designed for use in compounding a controlled substance;
- A capsule, balloon, envelope, or other container used, intended for use, or designed for use in packaging a small quantity of a controlled substance;
- A container or other object used, intended for use, or designed for use in storing or concealing a controlled substance;
- A hypodermic syringe, needle, or other object used, intended for use, or designed for use in parenterally injecting a controlled substance into the human body; and
-
An object used, intended for use, or designed for use in ingesting, inhaling, or otherwise introducing a controlled substance into the human body, such as:
- A metal, wooden, acrylic, glass, stone, plastic, or ceramic pipe with or without a screen, permanent screen, hashish head, or punctured metal bowl;
- A water pipe;
- A carburetion tube or device;
- A smoking or carburetion mask;
- A roach clip, meaning an object used to hold burning material, such as a marijuana cigarette that has become too small or too short to be held in the hand;
- A miniature cocaine spoon or cocaine vial;
- A chamber pipe;
- A carburetor pipe;
- An electric pipe;
- An air-driven pipe;
- A chillum;
- A bong;
- An ice pipe or chiller; and
- An aluminum foil boat.
-
In determining whether an object is “drug paraphernalia”, a court or other authority shall consider, in addition to any other logically relevant factor, the following:
- A statement by an owner or by anyone in control of the object concerning its use;
- A prior conviction, if any, of an owner or of anyone in control of the object under any state or federal law relating to any controlled substance;
- The proximity of the object in time and space to a direct violation of this chapter;
- The proximity of the object to a controlled substance;
- The existence of any residue of a controlled substance on the object;
-
- Direct or circumstantial evidence of the intent of an owner or of anyone in control of the object to deliver it to a person whom he or she knows, or should reasonably know, intends to use the object to facilitate a violation of this chapter.
- The innocence of an owner or of anyone in control of the object as to a direct violation of this chapter does not prevent a finding that the object is intended for use or designed for use as “drug paraphernalia”;
- An oral or written instruction provided with the object concerning its use;
- Descriptive materials accompanying the object that explain or depict its use;
- National and local advertising concerning the object's use;
- The manner in which the object is displayed for sale;
- Whether the owner or anyone in control of the object is a legitimate supplier of a like or related item to the community, such as a licensed distributor or dealer of a tobacco product;
- Direct or circumstantial evidence of the ratio of sales of the objects to the total sales of the business enterprise;
- The existence and scope of legitimate uses for the object in the community; and
- Expert testimony concerning the object's use;
- “Immediate precursor” means a substance that the secretary has found to be and by rule designates as being the principal compound commonly used or produced primarily for use, and that is an immediate chemical intermediary used or likely to be used in the manufacture of a controlled substance, the control of which is necessary to prevent, curtail, or limit manufacture;
-
- “Manufacture” means the production, preparation, propagation, compounding, conversion, or processing of a controlled substance, either directly or indirectly by extraction from a substance of natural origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis.
- “Manufacture” includes any packaging or repackaging of a controlled substance or labeling or relabeling of a controlled substance's container.
-
However, “manufacture” does not include the preparation or compounding of a controlled substance by an individual for his or her own use or the preparation, compounding, packaging, or labeling of a controlled substance:
- By a practitioner as an incident to his or her administering or dispensing of a controlled substance in the course of his or her professional practice; or
- By a practitioner or by his or her authorized agent under his or her supervision for the purpose of, or as an incident to, research, teaching, or chemical analysis and not for sale;
-
-
“Marijuana” means:
- Any part and any variety or species, or both, of the Cannabis plant that contains THC (Tetrahydrocannabinol) whether growing or not;
- The seeds of the plant;
- The resin extracted from any part of the plant; and
- Every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or resin.
-
“Marijuana” does not include:
- The mature stalks of the plant;
- Fiber produced from the stalks;
- Oil or cake made from the seeds of the plant;
-
Any other compound, manufacture, salt, derivative, mixture, or preparation of the:
- Mature stalks, except the resin extracted from the mature stalks;
- Fiber;
- Oil; or
- Cake;
- The sterilized seed of the plant that is incapable of germination; or
-
Hemp-derived cannabidiol that:
- Contains not more than three-tenths of one percent (0.3%) of tetrahydrocannabinol (THC) on a dry weight basis as verified by a nationally accredited laboratory for quality, purity, and accuracy standards; and
- Is not approved by the United States Food and Drug Administration for marketing as a medication;
-
“Marijuana” means:
-
-
- “Narcotic drug” means any drug that is defined as a narcotic drug by order of the secretary.
-
In the formulation of a definition of “narcotic drug”, the secretary shall:
- Include any drug that he or she finds is narcotic in character and by reason of being narcotic is dangerous to the public health or is promotive of addiction-forming or addiction-sustaining results upon the user that threaten harm to the public health, safety, or morals; and
- Take into consideration the provisions of the federal narcotic laws as they exist from time to time and shall amend the definitions so as to keep them in harmony with the definitions prescribed by the federal narcotic laws, so far as is possible under the standards established in this subdivision (16) and under the policy of this chapter.
-
“Narcotic drug” also means any of the following, whether produced directly or indirectly by extraction from a substance of vegetable origin, independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis:
-
- Opium, opiates, a derivative of opium or opiates, including their isomers, esters, and ethers whenever the existence of the isomers, esters, ethers, and salts is possible within the specific chemical designation.
- “Narcotic drug” does not include an isoquinoline alkaloid of opium;
- Poppy straw and concentrate of poppy straw;
- Coca leaves, except coca leaves and extracts of coca leaves from which cocaines, ecgonine, and derivatives of ecgonine or their salts have been removed;
- Cocaine, its salts, optical and geometric isomers, and salts of isomers;
- Ecgonine, its derivatives, their salts, isomers, and salts of isomers; or
- Any compound, mixture, or preparation that contains any quantity of any substance referred to in subdivisions (16)(B)(i)-(v) of this section;
-
-
- “Noncontrolled substance” means any liquid, substance, or material not listed in Schedules I through VI of the Schedules of Controlled Substances promulgated by the secretary;
- “Person” means an individual, corporation, government or governmental subdivision or agency, business trust, estate, trust, partnership or association, or any other legal entity;
-
“Practitioner” means:
- A physician, dentist, veterinarian, scientific investigator, or other person licensed, registered, or otherwise permitted to distribute, dispense, conduct research with respect to, or to administer a controlled substance in the course of professional practice or research in this state; and
- A pharmacy, hospital, or other institution licensed, registered, or otherwise permitted to distribute, dispense, conduct research with respect to, or to administer a controlled substance in the course of professional practice or research in this state;
- “Production” includes the manufacture, planting, cultivation, growing, or harvesting of a controlled substance;
- “State” when applied to a part of the United States, includes any state, district, commonwealth, territory, insular possession thereof, and any area subject to the legal authority of the United States of America; and
-
“Ultimate user” means a person who lawfully possesses a controlled substance for:
- The person's own use;
- The use of a member of the person's household; or
- Administering to an animal owned by the person or by a member of his or her household.
History. Acts 1971, No. 590, Art. 1, § 1; 1975, No. 243, § 1; 1975, No. 305, § 1; 1979, No. 898, §§ 1, 2; 1981, No. 78, § 1; 1981, No. 116, § 1; 1983, No. 787, §§ 1, 2; A.S.A. 1947, § 82-2601; Acts 1987, No. 42, § 2; 1991, No. 570, § 1; 1995, No. 1296, § 7; 2005, No. 1994, § 301; 2007, No. 199, § 1; 2007, No. 827, §§ 52–55; 2019, No. 504, § 1; 2019, No. 910, § 4830.
Amendments. The 2019 amendment by No. 504 added (15)(B)(vi).
The 2019 amendment by No. 910 substituted “Secretary” for “Director” in (3)(B)(i).
Research References
Ark. L. Rev.
Carroll, Uniform Laws in Arkansas, 52 Ark. L. Rev. 313.
U. Ark. Little Rock L.J.
Legislative Survey, Criminal Law, 4 U. Ark. Little Rock L.J. 583.
Legislation of the 1983 General Assembly, Criminal Law, 6 U. Ark. Little Rock L.J. 613.
Legislative Survey, Criminal Law, 8 U. Ark. Little Rock L.J. 559.
Case Notes
Constitutionality.
Although the defendant offered testimony that marijuana was not as harmful as alcohol or tobacco, the evidence presented by the defendant was not so overwhelming and uncontradicted as to convince the court that the Controlled Substances Act was arbitrary, capricious and unreasonable and, therefore, violated the due process clause and the equal protection clause of the United States Constitution.Bushong v. State, 267 Ark. 113, 589 S.W.2d 559 (1979), cert. denied, 446 U.S. 938, 100 S. Ct. 2157, 64 L. Ed. 2d 791 (1980).
Former subsection (y) of this section (see now subdivision (12)) and former § 5-64-403(c)(1) (see now § 5-64-443) concerning the term “drug paraphernalia” are not unconstitutionally vague for want of “certainty” or “definiteness,” since they give a person of ordinary intelligence fair notice that his contemplated conduct is forbidden. Moore v. State, 297 Ark. 296, 761 S.W.2d 894 (1988).
The drug paraphernalia law is not unconstitutionally vague, because the detailed definitions found in the statute give adequate notice of conduct constituting the offense. Crail v. State, 309 Ark. 120, 827 S.W.2d 157 (1992).
Controlled Substance.
When doubts as to construction of use of term “controlled substance” in definition section was considered in light of strict construction, possession of drugs classified in schedule of act to provide separate classifications for marijuana and another substance did not constitute a misdemeanor. White v. State, 260 Ark. 361, 538 S.W.2d 550 (1976).
Cocaine is a Schedule II controlled substance. Briggs v. State, 18 Ark. App. 292, 715 S.W.2d 223 (1986).
Evidence was sufficient to support defendant's conviction for possession of methamphetamine with intent to deliver where defendant had control over the 16 grams of methamphetamine, he stated that he had already sold some before arriving at the motel, and defendant offered to sell the remainder to an undercover police officer. Dodson v. State, 358 Ark. 372, 191 S.W.3d 511 (2004).
Deliver or Delivery.
Defendant who testified that the sale of drugs was actually between the officer and a third person, although he did get the drugs and give them to the officer and took the money for the drugs and gave it to the third person, was properly convicted for violating Controlled Substances Act. Snelling v. State, 257 Ark. 602, 519 S.W.2d 52 (1975).
Under the definition of deliver or delivery it makes no difference, on a motion for directed verdict, whether the transferor acts as an agent for the purchaser or the seller. Curry v. State, 258 Ark. 528, 527 S.W.2d 902 (1975).
Person who drove parties to address where sale of controlled substance was made could not defend on ground that he was a mere bystander where there was substantial evidence to show that he not only stood by, but aided, abetted and assisted in the delivery. Fant v. State, 258 Ark. 1015, 530 S.W.2d 364 (1975).
Where the defendant simply introduced the undercover officers to the sellers of controlled substance from whom the officers bought some controlled substance, the defendant was not guilty of delivering controlled substance since he would have had to take a more active part to be a principal or even an accomplice. Daigger v. State, 268 Ark. 249, 595 S.W.2d 653 (1980).
The exchange of something of value is not essential to the offense of delivery of a controlled substance. Anderson v. State, 275 Ark. 298, 630 S.W.2d 23 (1982).
The requirement that delivery be “in exchange for money or anything of value” was intended to make the comparatively severe penalty for delivery inapplicable to a gratuitous transfer, such as the action of two or more persons in smoking one marijuana cigarette by passing it around; the legislature, however, left intact the Uniform Act's provision that a delivery includes an attempted transfer and, accordingly, where the jury could find from substantial evidence that defendant attempted to transfer controlled substance in exchange for an agreed sum of money and had completed his part of the transaction, the proof was sufficient to support conviction even though the exchange of money was not completed. Anderson v. State, 275 Ark. 298, 630 S.W.2d 23 (1982).
Subdivision (f) of this section (see now subdivision (6)) only requires the attempted transfer of drugs in exchange for an agreed price; the exchange of drugs for money or anything of value is not essential to the commission of the offense. Marshall v. State, 289 Ark. 462, 712 S.W.2d 894 (1986).
Definition of “sale” is included in the definition of “deliver” as both involve a transfer of an item in exchange for money. Dean v. State, 293 Ark. 75, 732 S.W.2d 855 (1987).
Prescription of a controlled substance by a licensed physician is not “delivery” of a controlled substance. Hales v. State, 299 Ark. 93, 771 S.W.2d 285 (1989).
The fact that an accused is the agent of a buyer or seller of drugs does not remove the transfer of rock cocaine from the coverage of subsection (f) (see now subdivision (6)). Parker v. State, 302 Ark. 509, 790 S.W.2d 894 (1990).
To convict a defendant of delivery, the state had to prove that the defendant actually or constructively transferred drugs for value to another person; to convict one of possession, the state had to show that the defendant exercised control or dominion over it. Pyle v. State, 314 Ark. 165, 862 S.W.2d 823 (1993), cert. denied, 510 U.S. 1197, 114 S. Ct. 1306, 127 L. Ed. 2d 657 (1994).
Under the definition of “deliver” in this section, it makes no difference whether the transferor acted as an agent of the purchaser or the seller; the act is condemned whenever the transfer is in exchange for money or anything of value. Christian v. State, 318 Ark. 813, 889 S.W.2d 717 (1994).
Where both a detective and a confidential informant testified as to the details of a controlled drug buy, the evidence showed that the informant was given $250 in marked money, fitted with an audio device, sent to an apartment where he met defendant, and left the apartment with a baggie containing 1.7794 grams of methamphetamine which he gave to the detective. There was substantial evidence of “delivery” within the meaning of subdivision (7) (see now subdivision (6)) of this section to support defendant's conviction for delivery of methamphetamine; the district court did not err by denying defendant's motion for a directed verdict. Phavixay v. State, 2009 Ark. 452, 352 S.W.3d 311 (2009).
Appellant's conviction for delivery of methamphetamine was affirmed because the jury was properly instructed that the witness's testimony must be corroborated and an officer and the witness both testified that the crime of delivery of methamphetamine occurred. Hall v. State, 2010 Ark. App. 717 (2010).
Trial court did not err in allowing the director of the drug task force to testify that drugs constituted something of value because it was appropriate rebuttal testimony as defendant denied taking any money but conceded he received a fraction of the drugs as payment; despite defendant's entrapment defense, the State was never relieved of its burden to prove that defendant facilitated the transaction in exchange for money or something of value beyond a reasonable doubt. Owens v. State, 2017 Ark. App. 109, 515 S.W.3d 625 (2017).
Evidence that defendant arranged the price and the location for the buy, combined with defendant's admission that he was a drug dealer and testimony about his method of operation, was substantial evidence that defendant constructively delivered methamphetamine, for purposes of his continuing criminal enterprise conviction. Hunter v. State, 2017 Ark. App. 256, 522 S.W.3d 793 (2017).
Drug Paraphernalia.
Acts 1981, No. 78 which, in pertinent part added subsection (y) (see now subdivision (12)), is not unconstitutionally overbroad even though the act may prevent persons from utilizing the expressions imprinted on, or the symbolic speech represented by the use of, drug paraphernalia. Garner v. White, 726 F.2d 1274 (8th Cir. 1984).
Where defendants were arrested in a parking lot after buying various items, including three packages of antihistamines, four cans of starter fluid, butane, and an air freshener, the evidence was insufficient to support a conviction of possession of drug paraphernalia with intent to manufacture methamphetamines; all of the items seized were legally obtained and had legitimate uses, and suspicion alone cannot support a conviction. Gilmore v. State, 79 Ark. App. 303, 87 S.W.3d 805 (2002).
Trial court properly admitted evidence of defendant's prior crimes because they fell within the exception to Ark. R. Evid. 404(b) in that they were independently relevant as proof of knowledge and intent to commit an offense; further, in determining whether an object is drug paraphernalia, courts are directed to consider prior convictions and expert testimony concerning its use. Cluck v. State, 365 Ark. 166, 226 S.W.3d 780 (2006).
Motion to dismiss was properly denied in a case involving possession with intent to use drug paraphernalia because a crack pipe constituted paraphernalia under this section; further, there was sufficient evidence of intent where defendant admitted the pipe was his, cocaine residue was found on the pipe, and defendant admitted to using it to smoke cocaine in the past. White v. State, 98 Ark. App. 366, 255 S.W.3d 881 (2007).
Sufficient evidence supported a finding that defendant possessed “drug paraphernalia” within the meaning of this section, with the intent to manufacture methamphetamine because the jury could choose to believe that he knew the iodine he possessed was going to be used to make methamphetamine. Ashley v. State, 2012 Ark. App. 131, 388 S.W.3d 914 (2012).
Evidence.
It is not essential to proof of the charge of attempting to deliver a controlled substance that the substance be produced in court if one sufficiently experienced with the substance could testify that it was indeed that substance. Marshall v. State, 289 Ark. 462, 712 S.W.2d 894 (1986).
Evidence was sufficient to meet test of substantiality and show delivery. Summers v. State, 300 Ark. 525, 780 S.W.2d 540 (1989).
Evidence was sufficient to establish delivery of controlled substance. Standridge v. Standridge, 304 Ark. 364, 803 S.W.2d 496 (1991).
Court erroneously precluded state from introducing evidence of officer concerning use of antenna, found on the defendant, as drug paraphernalia. State v. Crutchfield, 306 Ark. 104, 816 S.W.2d 884 (1991) (supplemental op. on rehearing).
Evidence sufficient to support conviction for delivery of a controlled substance. Ramey v. State, 42 Ark. App. 242, 857 S.W.2d 828 (1993).
Evidence sufficient to find that appellant engaged in a conspiracy to deliver marijuana. Ramey v. State, 42 Ark. App. 242, 857 S.W.2d 828 (1993).
Where officer asked defendant for consent to search home and defendant stated he wanted to call his attorney and went back into the house, and officer simply followed defendant into the house, officer's entry into the home was illegal and not supported by unequivocal proof of consent required by state caselaw; therefore, products seized as a result of the illegal entry and search were fruit of the poisonous tree and should have been suppressed. Stone v. State, 348 Ark. 661, 74 S.W.3d 591 (2002).
Sufficient evidence was presented to the jury from which they could conclude that defendant possessed certain items for the purpose of manufacturing methamphetamine despite the fact that there was no evidence of lithium which was necessary to the manufacturing process. Cherry v. State, 80 Ark. App. 222, 95 S.W.3d 5 (2003).
Evidence of manufacturing methamphetamine held sufficient where evidence other than the accomplices' testimony tended to a substantial degree to connect defendant with the commission of the crime, and where there was sufficient corroboration of the accomplices' testimony. Brown v. State, 82 Ark. App. 61, 110 S.W.3d 293 (2003).
State's failure to prove that a substance was a statutorily-defined “counterfeit substance” was fatal to defendant's criminal conviction for possession of a counterfeit substance with the intent to deliver, especially where there was no evidence of attempted delivery; the only factor that the state proved was that the physical appearance of the finished product containing the noncontrolled substance was substantially the same as that of a specific controlled substance. Jackson v. State, 86 Ark. App. 145, 165 S.W.3d 467 (2004).
Evidence was sufficient to sustain a drug possession conviction where defendant was the driver of the car, the drugs were found directly behind the driver's seat, and he exercised dominion and control over the vehicle; in addition, defendant possessed 883.9 milligrams of the methamphetamine compound, which was a usable amount. Jones v. State, 357 Ark. 545, 182 S.W.3d 485 (2004).
Evidence was sufficient to sustain a drug paraphernalia possession conviction where the syringe in defendant's pocket was in close proximity to the methamphetamine found in the plastic bags behind his driver's seat. Jones v. State, 357 Ark. 545, 182 S.W.3d 485 (2004).
Given that defendant owned the premises, that drugs and paraphernalia were found in common areas throughout the residence, and that methamphetamine and paraphernalia were found in his pocket, there was sufficient evidence whereby a jury could convict defendant of manufacturing methamphetamine. Lueken v. State, 88 Ark. App. 323, 198 S.W.3d 547 (2004).
Evidence was sufficient to sustain a conviction for possession of drug paraphernalia with intent to manufacture methamphetamine where the jury had before it evidence of the items found at defendant's residence and in his vehicle (including hydrogen peroxide, isopropyl alcohol, an empty can of toluene, lye, salt, drain cleaner, muriatic acid, allergy pills, PVC gloves, a piece of tubing, and a syringe), but it was also informed of defendant's iodine purchase and of his prior convictions relating to methamphetamine in addition to the expert testimony concerning how the items found in defendant's possession are used to manufacture methamphetamine; neither statute nor case law required that all the ingredients necessary to manufacture methamphetamine be found in a defendant's possession. Cluck v. State, 365 Ark. 166, 226 S.W.3d 780 (2006).
Based on the evidence indicating defendant's proximity to the manufacturing paraphernalia, the jury could reasonably infer that she had joint possession and control of the contraband; it was undisputed that defendant had been occupying the residence for at least two weeks and she was present in the residence when methamphetamine was being manufactured and that she knew methamphetamine was being manufactured. Holt v. State, 2009 Ark. 482, 348 S.W.3d 562 (2009).
Trial court clearly did not err in denying the motion for directed verdict or its renewal, because the evidence was sufficient to convict defendant of possession of a counterfeit controlled substance, when the soap substance was packaged in a quantity and shape that had all the outward indications of appearing to be crack cocaine, and defendant stated in response to the officer's query that he thought he was getting cocaine. Caldwell v. State, 2009 Ark. App. 526, 334 S.W.3d 82 (2009).
Manufacture and Production.
Statute makes it clear that the growing or cultivation of marijuana is included in the offense of manufacturing; the definition of “manufacture” includes “production” and the definition of “production” includes “cultivation” of a controlled substance. Shepherd v. State, 256 Ark. 134, 506 S.W.2d 553, cert. denied, 419 U.S. 808, 95 S. Ct. 20, 42 L. Ed. 2d 34 (1974).
Manufacture as defined in this section does not include the preparation for one's own use. Bedell v. State, 257 Ark. 895, 521 S.W.2d 200 (1975).
Since the personal-use exemption provided for in subdivision (m) (now subdivision (14)) applies only to the preparation or compounding of a controlled substance and not to “production” which includes cultivating or harvesting the substance, defendant, who admitted growing marijuana on his farm, was not within that exception to the offense of manufacturing marijuana. Bedell v. State, 260 Ark. 401, 541 S.W.2d 297 (1976), cert. denied, 430 U.S. 931, 97 S. Ct. 1552, 51 L. Ed. 2d 775 (1977).
The personal use exemption provided for in subdivision (m) (now subdivision (14)) did not apply to defendant who manufactured from marijuana seeds and plants a tea and juice which defendant claimed to drink for the cure and prevention of cancer. Patty v. State, 260 Ark. 539, 542 S.W.2d 494 (1976).
The substance does not have to be in a form to be sold before a “manufacture” occurs. Lee v. State, 297 Ark. 421, 762 S.W.2d 790 (1989).
Although anhydrous ammonia, which was necessary to the methamphetamine manufacturing process, was not found, the state's chemist testified that ammonia was found, as well as other indications regarding the presence of anhydrous ammonia, which could not be specifically tested for, and that there was not an active manufacture taking place when the police arrived; thus, the chemist's testimony sufficiently explained the absence of the anhydrous ammonia in a lab where manufacturing had already occurred and the evidence was sufficient to convict defendant of manufacturing methamphetamine. Aydelotte v. State, 85 Ark. App. 67, 146 S.W.3d 392 (2004).
Evidence was sufficient to sustain a conviction for manufacturing methamphetamine where multiple ingredients and devices used in methamphetamine production were found together with the by-products of such production in defendant's van, as well as actual methamphetamine. Saul v. State, 365 Ark. 77, 225 S.W.3d 373 (2006).
Defense counsel was not ineffective for not objecting that defendants' convictions violated double jeopardy under § 5-1-110(b) because possession of drug paraphernalia with intent to manufacture methamphetamine was not a lesser-included offense of manufacturing methamphetamine. Myers v. State, 2012 Ark. 143, 400 S.W.3d 231 (2012).
Marijuana.
In prosecution for sale of marijuana it was not necessary for the state to show that the substance introduced into evidence as marijuana did not fall within any exemption provision of the definition of marijuana. Garner v. State, 258 Ark. 321, 524 S.W.2d 223 (1975); Rogers v. State, 258 Ark. 314, 524 S.W.2d 227, cert. denied, 423 U.S. 995, 96 S. Ct. 423, 46 L. Ed. 2d 369 (1975).
This section's definition of marijuana does not require the State to prove the presence of THC in order to obtain a conviction for possession of marijuana; lay testimony may provide substantial evidence of the identity of a controlled substance, even in the absence of expert chemical analysis. Springston v. State, 327 Ark. 90, 936 S.W.2d 550 (1997).
Narcotic Drug.
Cocaine is defined as a “narcotic drug” under this section and is made a Schedule II controlled substance under the terms of a board regulation adopted in accordance with § 5-64-205. Lively v. State, 25 Ark. App. 198, 755 S.W.2d 238 (1988).
Cited: Fight v. State, 254 Ark. 927, 497 S.W.2d 262 (1973); Sims v. State, 255 Ark. 87, 499 S.W.2d 54 (1973); Henderson v. State, 255 Ark. 870, 503 S.W.2d 889 (1974); Ark. State Medical Bd. v. Cross, 256 Ark. 388, 507 S.W.2d 709 (1974); Tate v. State, 258 Ark. 135, 524 S.W.2d 624 (1975); Ryan v. State, 260 Ark. 270, 538 S.W.2d 702 (1976); Hosto v. Brickell, 265 Ark. 147, 577 S.W.2d 401 (1979); Parker v. State, 265 Ark. 315, 578 S.W.2d 206 (1979); Hays v. State, 268 Ark. 701, 597 S.W.2d 821 (Ct. App. 1980); Young v. State, 269 Ark. 12, 598 S.W.2d 74 (1980); Johnson v. State, 6 Ark. App. 78, 638 S.W.2d 686 (1982); Jackson v. State, 283 Ark. 301, 675 S.W.2d 820 (1984); Harrod v. State, 286 Ark. 277, 691 S.W.2d 172 (1985); Webber v. State, 15 Ark. App. 261, 692 S.W.2d 255 (1985); Edwards v. State, 300 Ark. 4, 775 S.W.2d 900 (1989); Barlow v. State, 28 Ark. App. 21, 770 S.W.2d 186 (1989); Booker v. State, 32 Ark. App. 94, 796 S.W.2d 854 (1990); Smith v. State, 34 Ark. App. 72, 805 S.W.2d 663 (1991); Kellogg v. State, 37 Ark. App. 162, 827 S.W.2d 166 (1992); Enos v. State, 313 Ark. 683, 858 S.W.2d 72 (1993); Owens v. State, 325 Ark. 110, 926 S.W.2d 650 (1996); Williams v. State, 328 Ark. 487, 944 S.W.2d 822 (1997); Hyde v. State, 59 Ark. App. 131, 953 S.W.2d 911 (1997); Stanton v. State, 344 Ark. 589, 42 S.W.3d 474 (2001); Dodson v. State, 88 Ark. App. 380, 199 S.W.3d 115 (2004); Benjamin v. State, 102 Ark. App. 309, 285 S.W.3d 264 (2008); Morgan v. State, 2009 Ark. 257, 308 S.W.3d 147 (2009); Payne v. State, 2017 Ark. App. 263, 520 S.W.3d 719 (2017).
Subchapter 2 — Uniform Controlled Substances Act — Designation of Controlled Substances
Publisher's Notes. Schedules I through VI referred to in this subchapter are partly codified and partly governed by administrative regulation. The Director of the Department of Health or his or her authorized agent revises and republishes the schedules annually. For a copy of the most recent rescheduling of controlled substances, contact the Department of Health.
Acts 1979, No. 898, § 21 provided, in part, that the schedules in effect on July 20, 1979 should remain in effect until rescheduled.
For Comments regarding the Uniform Controlled Substances Act, see Commentaries Volume B.
Effective Dates. Acts 2005, No. 256, § 7: Mar. 24, 2005. Emergency clause provided: “It is hereby found and determined by the Eighty-fifth General Assembly that the effectiveness of this act is essential to the safety of the citizens of Arkansas; that excessive and improper exposure to illicit clandestine laboratories for the manufacture of methamphetamine causes harm to citizens of Arkansas; and that a delay in the effective date of this act beyond thirty days needed to implement it would unnecessarily expose the citizens of Arkansas to the risk of irreparable harm. Therefore, an emergency is declared to exist and this act being immediately necessary for the preservation of the public peace, health, and safety shall be effective on: (1) Thirty (30) days from and after the date of its passage and approval; (2) If the bill is neither approved nor vetoed by the Governor, it shall become effective thirty (30) days from the expiration of the period of time during which the Governor may veto the bill; or (3) If the bill is vetoed by the Governor and the veto is overridden, it shall become effective thirty (30) days from the date the last house overrides the veto.”
Acts 2011, No. 751, § 3: Mar. 28, 2011. Emergency clause provided: “It is found and determined by the General Assembly of the State of Arkansas that new substances that need immediate scheduling are becoming more prevalent; and that this act is immediately necessary because these new substances pose a risk to the public. Therefore, an emergency is declared to exist and this act being immediately necessary for the preservation of the public peace, health, and safety shall become effective on: (1) The date of its approval by the Governor; (2) If the bill is neither approved nor vetoed by the Governor, the expiration of the period of time during which the Governor may veto the bill; or (3) If the bill is vetoed by the Governor and the veto is overridden, the date the last house overrides the veto.”
Acts 2019, No. 910, § 6346(b): July 1, 2019. Emergency clause provided: “It is found and determined by the General Assembly of the State of Arkansas that this act revises the duties of certain state entities; that this act establishes new departments of the state; that these revisions impact the expenses and operations of state government; and that the sections of this act other than the two uncodified sections of this act preceding the emergency clause titled ‘Funding and classification of cabinet-level department secretaries’ and ‘Transformation and Efficiencies Act transition team’ should become effective at the beginning of the fiscal year to allow for implementation of the new provisions at the beginning of the fiscal year. Therefore, an emergency is declared to exist, and Sections 1 through 6343 of this act being necessary for the preservation of the public peace, health, and safety shall become effective on July 1, 2019”.